Epidemiology and pharmacogenetics
1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer
(
- Contribution to journal › Article
-
Mark
Endogenous incretin levels and risk of first incident cancer: a prospective cohort study
(
- Contribution to journal › Article
- 2022
-
Mark
Research Paper Impact of combining vitamin C with radiation therapy in human breast cancer : Does it matter?
(
- Contribution to journal › Article
-
Mark
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Body constitution, statin use, and tumor characteristics. Implications for prognosis.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence : A Nested Case-Control Study
(
- Contribution to journal › Article
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
(
- Contribution to journal › Article
- 2020
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
(
- Contribution to journal › Article